Patents Assigned to PRECISION MOLECULAR INC.
  • Therapeutic constructs for treating cancer
    Patent number: 12233135
    Abstract: The present disclosure provides nucleic acid constructs for the treatment of cancer, comprising a cancer-specific promoter and one or more therapeutic genes.
    Type: Grant
    Filed: April 10, 2019
    Date of Patent: February 25, 2025
    Assignee: PRECISION MOLECULAR INC.
    Inventors: Christopher Ullman, Christine Anne Carrington